since December Gregory A. Gould
2017
In 2017, since December Gregory A. Gould earned a total compensation of $622K as Chief Financial Officer at AYTU BIOPHARMA.
Compensation breakdown
| Option Awards | $79,000 |
|---|---|
| Salary | $10,000 |
| Stock Awards | $533,000 |
| Total | $622,000 |
Gould received $533K in stock awards, accounting for 86% of the total pay in 2017.
Gould also received $79K in option awards and $10K in salary.
Rankings
In 2017, since December Gregory A. Gould's compensation ranked 11,060th out of 14,666 executives tracked by ExecPay. In other words, Gould earned more than 24.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,060 out of 14,666 | 25th |
Division Manufacturing | 4,321 out of 5,768 | 25th |
Major group Chemicals And Allied Products | 1,562 out of 2,074 | 25th |
Industry group Drugs | 1,282 out of 1,730 | 26th |
Industry Pharmaceutical Preparations | 998 out of 1,329 | 25th |
Source: SEC filing on February 25, 2019.
Gould's colleagues
We found two more compensation records of executives who worked with since December Gregory A. Gould at AYTU BIOPHARMA in 2017.